Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vishal Kumar Sahu"'
Publikováno v:
Food Chemistry Advances, Vol 2, Iss , Pp 100321- (2023)
Non-coding RNA (ncRNAs) is greatly known to be involved in many cellular processes such as growth and development including tumorigenesis. Alterations in expression of ncRNAs are observed in several cancers. Therefore, they are regarded as potential
Externí odkaz:
https://doaj.org/article/33da8dffe3d74737ad9904015bb7774f
Publikováno v:
Cells, Vol 11, Iss 20, p 3215 (2022)
Peroxisome proliferator-activated receptor-γ (PPAR-γ) has emerged as one of the most extensively studied transcription factors since its discovery in 1990, highlighting its importance in the etiology and treatment of numerous diseases involving var
Externí odkaz:
https://doaj.org/article/e3dbe2d5e6e94818b141e5f98aa912aa
Autor:
Dayanand Swami, Priyanka Mudaliar, Yash Shrinivas Bichu, Vishal Kumar Sahu, Shine Devarajan, Soumya Basu, Jyotirmoi Aich
Publikováno v:
Journal of Biomolecular Structure and Dynamics. :1-15
HIV-protease inhibitor Ritonavir (RTV) is a clinical-stage drug. We exhibit here the synergistic effect of RTV coupled with cisplatin as potential combination therapy for treatment of cervical cancer. Knowledge about the interaction of RTV with the h
Autor:
Soumya Basu, Sangeeta Ballav, Kiran Bharat Lokhande, Vishal Kumar Sahu, Rohit Singh Yadav, K. Venkateswara Swamy
Publikováno v:
Letters in Drug Design & Discovery. 20
Background: Drug resistance in cancer is a serious threat to human well-being. There is a dire need to develop novel and efficient lead molecules to treat the disease. In lieu of anti-cancer activities, Peroxisome proliferator–activated receptors (